Inaedis Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.25M

  • Investors
  • 7

Inaedis General Information

Description

Developer of a biopharmaceutical technology designed to enable patient-centric biologic drug administration and shelf stability. The company's technology utilizes room-temperature aerosol dehydration, ultra-fine droplet formation, millisecond-scale drying, continuous processing, digital twin validation, and infrastructure retrofitting, enabling pharmaceutical companies with ultra-concentrated monoclonal antibodies, cold chain-free biologics, inhaled biologic formulations, intranasal vaccine powders, suspension-based drug products, and shelf-stable particles.

Contact Information

Website
www.inaedis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 114 Castleton Road
  • Princeton, NJ 08540-1674
  • United States
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Corporate Office
  • 114 Castleton Road
  • Princeton, NJ 08540-1674
  • United States

Inaedis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inaedis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 09-Sep-2025 $1.25M Completed Generating Revenue
6. Accelerator/Incubator 30-Oct-2024 Completed Generating Revenue
5. Grant 20-Mar-2024 Completed Generating Revenue
4. Early Stage VC 27-Feb-2024 Completed Generating Revenue
3. Grant 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator 13-Oct-2023 Completed Generating Revenue
1. Grant 15-Sep-2023 $275K Completed Startup
To view Inaedis’s complete valuation and funding history, request access »

Inaedis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biopharmaceutical technology designed to enable patient-centric biologic drug administration and shelf st
Drug Delivery
Princeton, NJ
5 As of 2026

Oxford, United Kingdom
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Inaedis Competitors (9)

One of Inaedis’s 9 competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
BPS Bioscience Corporation San Diego, CA
VMRD Corporation Pullman, WA
CD Genomics Corporation Shirley, NY
Crown Bioscience Formerly VC-backed San Diego, CA
You’re viewing 5 of 9 competitors. Get the full list »

Inaedis Patents

Inaedis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226490-A1 Method and system for formulation of ultra-high concentration suspensions of proteins and biologics Pending 20-Apr-2025
WO-2025217414-A1 Method and system for thermal stabilization of pharmaceutical formulations containing enveloped and nonenveloped virus particles Pending 11-Apr-2024

Inaedis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inaedis Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Merck Digital Sciences Studio Accelerator/Incubator
New Jersey Economic Development Authority Government
Princeton Innovation Center BioLabs Accelerator/Incubator Minority
Roadrunner Venture Studios Accelerator/Incubator Minority
U.S. Department of Health and Human Services Government
You’re viewing 5 of 7 investors. Get the full list »

Inaedis FAQs

  • When was Inaedis founded?

    Inaedis was founded in 2022.

  • Where is Inaedis headquartered?

    Inaedis is headquartered in Princeton, NJ.

  • What is the size of Inaedis?

    Inaedis has 5 total employees.

  • What industry is Inaedis in?

    Inaedis’s primary industry is Drug Delivery.

  • Is Inaedis a private or public company?

    Inaedis is a Private company.

  • What is Inaedis’s current revenue?

    The current revenue for Inaedis is .

  • Who are Inaedis’s investors?

    Merck Digital Sciences Studio, New Jersey Economic Development Authority, Princeton Innovation Center BioLabs, Roadrunner Venture Studios, and U.S. Department of Health and Human Services are 5 of 7 investors who have invested in Inaedis.

  • Who are Inaedis’s competitors?

    Oxford Nanopore Technologies, BPS Bioscience, VMRD, CD Genomics, and Crown Bioscience are some of the 9 competitors of Inaedis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process